- Report
- October 2020
- 59 Pages
Middle East, Africa
From €1439EUR$1,500USD£1,236GBP
- Report
- October 2020
- 59 Pages
Asia Pacific
From €1439EUR$1,500USD£1,236GBP
- Report
- July 2023
- 98 Pages
Global
From €3500EUR$3,908USD£3,112GBP
- Report
- December 2023
- 87 Pages
Global
From €3500EUR$3,908USD£3,112GBP
- Report
- December 2022
- 439 Pages
Global
From €3425EUR$3,570USD£2,942GBP
- Report
- June 2023
- 160 Pages
Global
From €5755EUR$5,999USD£4,944GBP
- Report
- May 2023
- 147 Pages
Global
From €5755EUR$5,999USD£4,944GBP
- Book
- January 2014
- 728 Pages
- Book
- September 2013
- 152 Pages
Amblyopia, also known as lazy eye, is a vision disorder in which the vision in one eye is reduced due to the lack of use. It is the most common cause of vision impairment in children and is estimated to affect 2-3% of the population. Amblyopia is typically caused by misalignment of the eyes, unequal refractive errors, or a combination of both. Treatment for amblyopia typically involves the use of optical devices such as eyeglasses, contact lenses, and patching.
The amblyopia market is a subset of the optical market and is composed of companies that specialize in the diagnosis and treatment of amblyopia. These companies offer a variety of products and services, including eyeglasses, contact lenses, patching, vision therapy, and surgical treatments. Some of the major players in the amblyopia market include Essilor, Hoya, CooperVision, Bausch + Lomb, and Zeiss. Show Less Read more